| Histamine H3 receptor antagonists/inverse agonists: Where do they go? N Ghamari, O Zarei, JA Arias-Montaño, D Reiner, S Dastmalchi, H Stark, ... Pharmacology & Therapeutics 200, 69-84, 2019 | 66 | 2019 |
| The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium … N Eissa, S Azimullah, P Jayaprakash, RL Jayaraj, D Reiner, SK Ojha, ... Chemico-biological interactions 312, 108775, 2019 | 53 | 2019 |
| The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic … N Eissa, S Azimullah, P Jayaprakash, RL Jayaraj, D Reiner, SK Ojha, ... International journal of molecular sciences 21 (11), 3996, 2020 | 31 | 2020 |
| Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects N Ghamari, O Zarei, D Reiner, S Dastmalchi, H Stark, ... Chemical Biology & Drug Design 93 (5), 832-843, 2019 | 31 | 2019 |
| Novel naphthyloxy derivatives–potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation D Łażewska, M Kaleta, S Hagenow, S Mogilski, G Latacz, T Karcz, ... Bioorganic & Medicinal Chemistry 26 (9), 2573-2585, 2018 | 29 | 2018 |
| Design, synthesis, and biological evaluation of novel oxadiazole-and thiazole-based histamine H3R ligands MA Khanfar, D Reiner, S Hagenow, H Stark Bioorganic & Medicinal Chemistry 26 (14), 4034-4046, 2018 | 24 | 2018 |
| The Multi-Targeting Ligand ST-2223 with Histamine H3 Receptor and Dopamine D2/D3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive … N Eissa, K Venkatachalam, P Jayaprakash, M Falkenstein, M Dubiel, ... International journal of molecular sciences 22 (4), 1947, 2021 | 21 | 2021 |
| Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring D Reiner, H Stark European Journal of Pharmacology 848, 112-120, 2019 | 16 | 2019 |
| Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors D Łażewska, A Olejarz-Maciej, D Reiner, M Kaleta, G Latacz, M Zygmunt, ... International journal of molecular sciences 21 (10), 3411, 2020 | 14 | 2020 |
| Rasagiline derivatives combined with histamine H3 receptor properties K Lutsenko, S Hagenow, A Affini, D Reiner, H Stark Bioorganic & Medicinal Chemistry Letters 29 (19), 126612, 2019 | 14 | 2019 |
| In silico and in vitro studies of two non‐imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes N Ghamari, S Dastmalchi, O Zarei, JA Arias‐Montaño, D Reiner, ... Chemical Biology & Drug Design 95 (2), 279-290, 2020 | 13 | 2020 |
| Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease DE Hafez, M Dubiel, G La Spada, M Catto, D Reiner-Link, YT Syu, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2175821, 2023 | 12 | 2023 |
| Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease J Godyń, P Zaręba, D Łażewska, D Stary, D Reiner-Link, A Frank, ... Bioorganic Chemistry 114, 105129, 2021 | 11 | 2021 |
| Histamine H3 receptor antagonists with peptidomimetic (keto) piperazine structures to inhibit Aβ oligomerisation M Falkenstein, D Reiner-Link, A Zivkovic, I Gering, D Willbold, H Stark Bioorganic & medicinal chemistry 50, 116462, 2021 | 9 | 2021 |
| Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H3 receptor for Prader–Willi Syndrome D Reiner, L Seifert, C Deck, R Schüle, M Jung, H Stark Scientific Reports 10 (1), 13558, 2020 | 8 | 2020 |
| Profiling of LINS01 compounds at human dopamine D2 and D3 receptors MF Corrêa, D Reiner, GAB Fernandes, MT Varela, CMSQ Aranha, H Stark, ... Journal of Chemical Sciences 132, 1-6, 2020 | 7 | 2020 |
| Eosinophils adhesion assay as a tool for phenotypic drug screening-The pharmacology of 1, 3, 5–Triazine and 1H-indole like derivatives against the human histamine H4 receptor M Grosicki, M Adami, C Micheloni, M Głuch-Lutwin, A Siwek, G Latacz, ... European Journal of Pharmacology 890, 173611, 2021 | 6 | 2021 |
| Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties KJ Kuder, M Kotańska, K Szczepańska, K Mika, D Reiner-Link, H Stark, ... Molecules 26 (8), 2300, 2021 | 5 | 2021 |
| The Search for Histamine H4 Receptor Ligands with Anticancer Activity among Novel (Thio)urea Derivatives E Domínguez‐Álvarez, D Łażewska, Z Szabó, S Hagenow, D Reiner, ... ChemistrySelect 4 (36), 10943-10952, 2019 | 4 | 2019 |
| Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of … J Godyń, P Zaręba, D Stary, M Kaleta, KJ Kuder, G Latacz, S Mogilski, ... Molecules 28 (1), 238, 2022 | 3 | 2022 |
Holger StarkHeinrich Heine University Duesseldorf/GermanyVerified email at hhu.de
